Literature DB >> 12702734

Inhibition of protein kinase CbetaII increases glucose uptake in 3T3-L1 adipocytes through elevated expression of glucose transporter 1 at the plasma membrane.

Remko R Bosch1, Merlijn Bazuine, Michelle M Wake, Paul N Span, André J Olthaar, Annette Schürmann, J Antonie Maassen, Ad R M M Hermus, Peter H G M Willems, C G J Sweep.   

Abstract

The mechanism via which diacylglycerol-sensitive protein kinase Cs (PKCs) stimulate glucose transport in insulin-sensitive tissues is poorly defined. Phorbol esters, such as phorbol-12-myristate-13-acetate (PMA), are potent activators of conventional and novel PKCs. Addition of PMA increases the rate of glucose uptake in many different cell systems. We attempted to investigate the mechanism via which PMA stimulates glucose transport in 3T3-L1 adipocytes in more detail. We observed a good correlation between the rate of disappearance of PKCbetaII during prolonged PMA treatment and the increase in glucose uptake. Moreover, inhibition of PKCbetaII with a specific myristoylated PKCbetaC2-4 peptide inhibitor significantly increased the rate of glucose transport. Western blot analysis demonstrated that both PMA treatment and incubation with the myristoylated PKCbetaC2-4 pseudosubstrate resulted in more glucose transporter (GLUT)-1 but not GLUT-4 at the plasma membrane. To our knowledge, we are the first to demonstrate that inactivation of PKC, most likely PKCbetaII, elevates glucose uptake in 3T3-L1 adipocytes. The observation that PKCbetaII influences the rate of glucose uptake through manipulation of GLUT-1 expression levels at the plasma membrane might reveal a yet unidentified regulatory mechanism involved in glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702734     DOI: 10.1210/me.2003-0057

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  5 in total

1.  Protein kinase C family members as a target for regulation of blood-brain barrier Na,K,2Cl-cotransporter during in vitro stroke conditions and nicotine exposure.

Authors:  Tianzhi Yang; Karen E Roder; G Jayarama Bhat; Thomas J Thekkumkara; Thomas J Abbruscato
Journal:  Pharm Res       Date:  2006-02-07       Impact factor: 4.200

2.  Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models.

Authors:  Joy L Kovar; William Volcheck; Eva Sevick-Muraca; Melanie A Simpson; D Michael Olive
Journal:  Anal Biochem       Date:  2008-10-07       Impact factor: 3.365

3.  Regulation of GLUT1-mediated glucose uptake by PKClambda-PKCbeta(II) interactions in 3T3-L1 adipocytes.

Authors:  Remko R Bosch; Merlijn Bazuine; Paul N Span; Peter H G M Willems; André J Olthaar; Helga van Rennes; J Antonie Maassen; Cees J Tack; Ad R M M Hermus; C G J Fred Sweep
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

4.  Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes.

Authors:  A R Shikhman; D C Brinson; J Valbracht; M K Lotz
Journal:  Osteoarthritis Cartilage       Date:  2009-03-24       Impact factor: 6.576

5.  Involvement of distinct PKC gene products in T cell functions.

Authors:  Christa Pfeifhofer-Obermair; Nikolaus Thuille; Gottfried Baier
Journal:  Front Immunol       Date:  2012-08-06       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.